• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁蛋白可预测鼻咽癌患者的预后。

Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.

机构信息

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China.

Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China.

出版信息

Sci Rep. 2024 Feb 21;14(1):4311. doi: 10.1038/s41598-024-54627-3.

DOI:10.1038/s41598-024-54627-3
PMID:38383702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10881573/
Abstract

Elevated serum ferritin (SF) levels have been associated with poor prognosis in various cancer types, but its impact on nasopharyngeal carcinoma (NPC) remains unclear. This retrospective study analyzed clinical data from 252 non-metastatic NPC patients admitted to Hainan General Hospital between January 2014 and May 2016. SF levels were measured using the chemiluminescence method. Patients were categorized into low, medium, and high-level SF groups based on tertile median SF levels. Survival outcomes were assessed using Kaplan-Meier analysis and Cox regression models. The overall survival rates of the entire patient cohort at 1, 3, 5, and 8 years were 95.2%, 85.7%, 76.2%, and 68.9% respectively. The high-level SF group (SF > 164.00 ng/mL) had significantly worse overall survival (83.1 vs 96.3 months, P = 0.023) and progression-free survival (77.8 vs 93.3 months, P = 0.019) compared to the low-level SF group. Univariate and multivariate analyses confirmed that high SF levels, along with T3/T4 staging and N3 staging, were independent risk factors for poor prognosis. In conclusion, high SF levels are associated with shorter overall survival and progression-free survival in NPC patients.

摘要

血清铁蛋白(SF)水平升高与多种癌症类型的预后不良有关,但它对鼻咽癌(NPC)的影响尚不清楚。本回顾性研究分析了 2014 年 1 月至 2016 年 5 月期间海南总医院收治的 252 例非转移性 NPC 患者的临床资料。采用化学发光法测量 SF 水平。根据三分位中位数 SF 水平将患者分为低、中、高水平 SF 组。采用 Kaplan-Meier 分析和 Cox 回归模型评估生存结局。整个患者队列的总生存率在 1、3、5 和 8 年时分别为 95.2%、85.7%、76.2%和 68.9%。高水平 SF 组(SF>164.00ng/mL)的总生存率(83.1 与 96.3 个月,P=0.023)和无进展生存率(77.8 与 93.3 个月,P=0.019)明显低于低水平 SF 组。单因素和多因素分析证实,高水平 SF 水平以及 T3/T4 分期和 N3 分期是预后不良的独立危险因素。总之,高水平 SF 与 NPC 患者的总生存时间和无进展生存时间缩短相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8353/10881573/571d71652ba3/41598_2024_54627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8353/10881573/571d71652ba3/41598_2024_54627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8353/10881573/571d71652ba3/41598_2024_54627_Fig1_HTML.jpg

相似文献

1
Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.血清铁蛋白可预测鼻咽癌患者的预后。
Sci Rep. 2024 Feb 21;14(1):4311. doi: 10.1038/s41598-024-54627-3.
2
Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.比较 UICC/AJCC 第七版和第八版鼻咽癌分期系统:两个中心 1317 例调强放疗患者的分析。
BMC Cancer. 2018 May 29;18(1):606. doi: 10.1186/s12885-018-4419-1.
3
Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.整合模型纳入转移性区域颈淋巴结体积和治疗前血清爱泼斯坦-巴尔病毒DNA拷贝数在预测N1期鼻咽癌患者远处转移中的预后价值
Chin J Cancer. 2017 Dec 29;36(1):98. doi: 10.1186/s40880-017-0264-x.
4
Construction of Prognostic Nomogram in Patients with N3-Stage Nasopharyngeal Carcinoma.构建 N3 期鼻咽癌患者的预后列线图。
ORL J Otorhinolaryngol Relat Spec. 2023;85(4):195-207. doi: 10.1159/000530053. Epub 2023 May 5.
5
The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study.调强适形放疗时代肿瘤原发灶体积对鼻咽癌预后的影响:倾向评分匹配队列研究。
Braz J Otorhinolaryngol. 2023 May-Jun;89(3):374-382. doi: 10.1016/j.bjorl.2023.02.002. Epub 2023 Feb 16.
6
Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.新辅助化疗能否提高 T3-4N1 期鼻咽癌患者的生存率?一项倾向评分匹配分析。
Radiat Oncol. 2020 Jul 2;15(1):160. doi: 10.1186/s13014-020-01594-4.
7
Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.鼻咽癌腮腺淋巴结转移的预后和分期:10126 例患者分析。
Oral Oncol. 2019 Aug;95:150-156. doi: 10.1016/j.oraloncology.2019.06.013. Epub 2019 Jun 22.
8
Prior cancer history predicts the worse survival of patients with nasopharyngeal carcinoma.既往癌症病史预示着鼻咽癌患者更差的生存结局。
Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5381-5387. doi: 10.1007/s00405-022-07444-1. Epub 2022 Jun 22.
9
Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.组织学亚型仍然是鼻咽癌患者生存的预后因素。
Laryngoscope. 2020 Mar;130(3):E83-E88. doi: 10.1002/lary.28099. Epub 2019 Jun 12.
10
Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.MRI 显示的咀嚼肌间隙受累情况对接受调强放疗的鼻咽癌患者的预后价值
Radiat Oncol. 2015 Sep 25;10:204. doi: 10.1186/s13014-015-0513-6.

本文引用的文献

1
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells.输注前血清铁蛋白、CRP 和 IL-6 联合预测 CAR-T 细胞治疗复发/难治性多发性骨髓瘤患者的结局。
Front Immunol. 2023 Apr 19;14:1169071. doi: 10.3389/fimmu.2023.1169071. eCollection 2023.
2
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.局部晚期复发性鼻咽癌患者调强放疗中加速分割与标准分割的比较:一项多中心、随机、开放标签的3期试验
Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23.
3
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.鼻咽坏死与无远处转移鼻咽癌的总生存有关:一个综合的列线图模型。
Eur Radiol. 2023 May;33(5):3682-3692. doi: 10.1007/s00330-023-09431-4. Epub 2023 Feb 3.
4
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.吉西他滨和顺铂诱导化疗治疗鼻咽癌的最终总生存分析:一项多中心、随机 III 期试验。
J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16.
5
A Nomogram Based on Circulating CD4 T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.基于循环CD4 T淋巴细胞和乳酸脱氢酶的列线图预测鼻咽癌患者远处转移
J Inflamm Res. 2021 Dec 9;14:6707-6718. doi: 10.2147/JIR.S341897. eCollection 2021.
6
Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?局部晚期鼻咽癌患者均能从 S-1/卡培他滨维持化疗中获益吗?
Oral Oncol. 2021 Nov;122:105539. doi: 10.1016/j.oraloncology.2021.105539. Epub 2021 Sep 20.
7
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance.脂滴与铁蛋白重链:人类癌细胞放射抵抗中的狼狈为奸。
Elife. 2021 Sep 9;10:e72943. doi: 10.7554/eLife.72943.
8
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.吉西他滨联合顺铂对比氟尿嘧啶联合顺铂作为复发或转移性鼻咽癌患者的一线治疗:GEM20110714 期研究最终总生存分析。
J Clin Oncol. 2021 Oct 10;39(29):3273-3282. doi: 10.1200/JCO.21.00396. Epub 2021 Aug 11.
9
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.节拍式卡培他滨作为局部晚期鼻咽癌辅助治疗:一项多中心、开放标签、平行分组、随机、对照、3 期临床试验。
Lancet. 2021 Jul 24;398(10297):303-313. doi: 10.1016/S0140-6736(21)01123-5. Epub 2021 Jun 7.
10
Role of iron in cancer.铁在癌症中的作用。
Semin Cancer Biol. 2021 Nov;76:189-194. doi: 10.1016/j.semcancer.2021.04.001. Epub 2021 Apr 24.